13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001922318
Total reported value
$1.4B
$1.4B
51 檔
26.0%
In Q4 2024, Pale Fire Capital SE's U.S. equity holdings reached a combined market value of $1.4B, distributed across 51 disclosed stock positions.
During Q4 2024, Pale Fire Capital SE's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including BTG, GRPN, DOLE) accounted for 26.0% of total reported equity market value during Q4 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BTG | B2gold CORP | Stock-Other | 29.02% | -10.69% | +205.01% | |
| 2 | GRPN | Groupon Inc | Stock-Other | 28.07% | +6.67% | — | |
| 3 | DOLE | Dole plc | Stock-Other | 19.04% | -2.69% | -5.33% | |
| 4 | INSW | International Seaways, Inc. | Stock-Other | 4.22% | — | -31.44% | |
| 5 | NVDA | Nvidia CORP | Stock-Tech | 3.14% | — | — | |
| 6 | CGAU | Centerra Gold Inc | Stock-Other | 2.93% | — | +2.54% | |
| 7 | QURE | uniQure N.V. | Stock-Other | 2.33% | — | +72.59% | |
| 8 | TEN | Tsakos Energy Navigation Limited | Stock-Other | 1.89% | — | -4.98% | |
| 9 | ANGI1EUR | Angi Inc | Stock-Other | 1.75% | — | -13.96% | |
| 10 | IAUX | I-80 Gold CORP | Stock-Other | 1.12% | -0.86% | +2.93% | |
| 11 | SSTK | Shutterstock Inc | Stock-Other | 0.88% | — | +32.71% | |
| 12 | OCUL | Ocular Therapeutix Inc | Stock-Other | 0.86% | — | +1.51% | |
| 13 | NMM | Navios Maritime Partners L.P. | Stock-Other | 0.83% | — | -50.45% | |
| 14 | CIM | Chimera Investment CORP | Stock-Other | 0.47% | — | -56.05% | |
| 15 | AQST | Aquestive Therapeutics Inc | Stock-Other | 0.42% | — | +2090.65% | |
| 16 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 0.38% | +0.30% | — | |
| 17 | AVU0 | Adverum Biotechnologies Inc | Stock-Other | 0.33% | — | +2.20% | |
| 18 | CRBU | Caribou Biosciences Inc | Stock-Other | 0.26% | — | -0.10% | |
| 19 | ASNSUSD | X4 Pharmaceuticals Inc | Stock-Other | 0.23% | — | -12.53% | |
| 20 | TDOC | Teladoc Health Inc | Stock-Healthcare | 0.23% | -0.45% | -94.56% | |
| 21 | STNG | Scorpio Tankers Inc. | Stock-Other | 0.17% | — | -66.38% | |
| 22 | ATAI | AtaiBeckley Inc. | Stock-Other | 0.15% | — | +1230.52% | |
| 23 | ✓ | Inozyme Pharma Inc | Stock-Other | 0.14% | — | +15.91% | |
| 24 | HELP | Cybin Inc | Stock-Other | 0.12% | +0.01% | — | |
| 25 | CMRXEUR | Chimerix Inc | Stock-Other | 0.08% | — | -58.22% | |
| 26 | MITT | Tpg Mortgage Investment Trus | Stock-Other | 0.08% | — | -61.58% | |
| 27 | IOVA | Iovance Biotherapeutics Inc | Stock-Other | 0.07% | — | +4.01% | |
| 28 | PRAX | Praxis Precision Medicines I | Stock-Other | 0.06% | — | -94.99% | |
| 29 | ✓ | Verve Therapeutics Inc | Stock-Other | 0.06% | — | -1.75% | |
| 30 | ETNBGBP | 89bio Inc | Stock-Other | 0.05% | — | — | |
| 31 | CELC | Celcuity Inc | Stock-Other | 0.05% | — | — | |
| 32 | ✓ | Immatics NV | Stock-Other | 0.05% | -0.01% | EXIT | |
| 33 | RZLT | Rezolute Inc | Stock-Other | 0.05% | — | +77.80% | |
| 34 | BHVN | Biohaven Ltd. | Stock-Other | 0.05% | — | — | |
| 35 | DAWNGBX | Day One Biopharmaceuticals I | Stock-Other | 0.05% | — | — | |
| 36 | ADAM | Adamas Trust Inc | Stock-Other | 0.04% | — | -86.87% | |
| 37 | ACHV | Achieve Life Sciences Inc | Stock-Other | 0.03% | — | +25.06% | |
| 38 | URGN | UroGen Pharma Ltd. | Stock-Other | 0.03% | — | — | |
| 39 | TCRX | Tscan Therapeutics Inc | Stock-Other | 0.03% | — | — | |
| 40 | LRMR | Larimar Therapeutics Inc | Stock-Other | 0.03% | +0.01% | NEW | |
| 41 | INDV | Indivior Pharmaceuticals, Inc. | Stock-Other | 0.03% | — | — | |
| 42 | LXEO | Lexeo Therapeutics Inc | Stock-Other | 0.02% | — | — | |
| 43 | NUVB | Nuvation Bio Inc | Stock-Other | 0.02% | — | — | |
| 44 | ✓ | Engene Holdings Inc | Stock-Other | 0.02% | -0.01% | EXIT | |
| 45 | ACRV | Acrivon Therapeutics Inc | Stock-Other | 0.02% | — | — | |
| 46 | RGNX | Regenxbio Inc | Stock-Other | 0.02% | +0.03% | — | |
| 47 | ✓ | Stock-Other | 0.02% | — | -18.42% | ||
| 48 | SGMT | Sagimet Biosciences Inc-a | Stock-Other | 0.02% | +0.02% | — | |
| 49 | ASPI | Asp Isotopes Inc | Stock-Other | 0.01% | — | — | |
| 50 | NEWP | New Pacific Metals CORP | Stock-Other | 0.01% | — | +25.65% |
According to official SEC Form 13F filings, Pale Fire Capital SE reported a total U.S. public equity portfolio value of $1.4B across 51 disclosed positions in Q4 2024.
During Q4 2024, Pale Fire Capital SE's top holdings by market value included BTG (29.0%)、GRPN (28.1%)、DOLE (19.0%). The largest single position, BTG, represented 29.0% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In Q4 2024, Pale Fire Capital SE made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.